Put a price on breakthroughs (alexwang.ai)

Neolabs, the emerging AI startups focused on high-risk research, are facing immense pressure to deliver both groundbreaking innovations and scalable business models simultaneously, a combination that drastically reduces their likelihood of success. This trend has sparked discussions about reforming how funding and acquisition strategies are structured in the AI/ML space. By adopting a "pull funding" approach, similar to models used in the pharmaceutical industry, where smaller biotech firms take on discovery risks and larger companies focus on scaling successful products, Neolabs could better concentrate on their research endeavors. The proposed solution involves pre-registered acquisitions, where frontier labs commit to acquiring neolabs based on specific research milestones and results. This arrangement mitigates the dual pressure of achieving both breakthrough research and commercial success, allowing researchers to focus on innovation while securing funding and potential acquisition from established companies. By making these commitments explicit, both parties can reduce uncertainty and align interests, transforming the odds of success from 1 in 10,000 to a more promising 1 in 100, thereby creating a more sustainable ecosystem for AI research and development.